VERTEX PHARMACEUTICALS INC / MA (VRTX) /
The revenue of VERTEX PHARMACEUTICALS INC / MA over the past 10 years
Chart VERTEX PHARMACEUTICALS INC / MA: revenue, fiscal 2016–2025 Open the chart →VERTEX PHARMACEUTICALS INC / MA reported revenue of $12B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $1.7B — up 605% over 9 years. Year over year, revenue rose every year. The largest one-year move was in fiscal 2020: up 49%, from $4.16B to $6.21B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $12B |
| 2024ended Dec 31, 2024 | $11.02B |
| 2023ended Dec 31, 2023 | $9.87B |
| 2022ended Dec 31, 2022 | $8.93B |
| 2021ended Dec 31, 2021 | $7.57B |
| 2020ended Dec 31, 2020 | $6.21B |
| 2019ended Dec 31, 2019 | $4.16B |
| 2018ended Dec 31, 2018 | $3.05B |
| 2017ended Dec 31, 2017 | $2.49B |
| 2016ended Dec 31, 2016 | $1.7B |
Fiscal years as VERTEX PHARMACEUTICALS INC / MA reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on VERTEX PHARMACEUTICALS INC / MA
- The profitability of VERTEX PHARMACEUTICALS INC / MA
- The cash flow of VERTEX PHARMACEUTICALS INC / MA
- The debt of VERTEX PHARMACEUTICALS INC / MA
- All of VERTEX PHARMACEUTICALS INC / MA's financials, charted
Companies of a similar size
- SPGIS&P Global Inc.
- PGRPROGRESSIVE CORP/OH/
- UBERUber Technologies, Inc
- FTNTFORTINET, INC.
- LMTLOCKHEED MARTIN CORPORATION
Not investment advice. This page shows what VERTEX PHARMACEUTICALS INC / MA filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.